Patent details

EP2247954 Title: SELECTION OF HEAD AND NECK CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY

Basic Information

Publication number:
EP2247954
PCT Application Number:
PCT/US/2009/006269
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097749949
PCT Publication Number:
WO/2010/085235
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SELECTION OF HEAD AND NECK CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY
French Title of Invention:
SÉLECTION DE PATIENTS SOUFFRANT DE CANCERS DE LA TÊTE ET DU COU EN VUE DE TRAITEMENTS PAR DES MÉDICAMENTS CIBLANT LE MÉCANISME EGFR
German Title of Invention:
AUSWAHL VON KOPF-HALS-KREBSPATIENTEN FÜR EINE BEHANDLUNG MIT ARZNEIMITTELN ZUR ANZIELUNG DES EGFR-PFADES
SPC Number:

Dates

Filing date:
20/11/2009
Grant date:
13/07/2011
EP Publication Date:
13/07/2011
PCT Publication Date:
29/07/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/11/2010
EP B1 Publication Date:
13/07/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/11/2011
Expiration date:
20/11/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/11/2009
 
 

Name:
Biodesix Inc.
Address:
P.O. Box 774872 1370 Bob Adams Drive, Steamboat Springs, CO 80477, United States (US)

Inventor

1

Name:
GRIGORIEVA Julia
Address:
United States (US)

2

Name:
RÖDER Heinrich
Address:
United States (US)

3

Name:
TSYPIN Maxim
Address:
United States (US)

Priority

Priority Number:
321393
Priority Date:
20/01/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
G01N 33/574;
Filing date Document type Number of pages